Nexstim has placed an NBT® System with SmartFocus® technology to Stanford University Medical Center
Helsinki, Finland: 14 October 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has placed an NBT® system with SmartFocus® TMS technology to Stanford University Medical Center, US.
Stanford University Medical Center uses the NBT® system for treatment of hospitalized patients suffering from treatment resistant depression. The first patient has already completed the SmartFocus® TMS therapy period there.
More info on Nexstim‘s website.